相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PBMCs: a new source of diagnostic and prognostic biomarkers
Meysam Mosallaei et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis
Xuan Zou et al.
CANCER BIOMARKERS (2021)
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
Eleni Anastasiadou et al.
CLINICAL CANCER RESEARCH (2021)
MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis
Xuan Zou et al.
GENE (2020)
Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review
Giacomo Setti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes
Gyeungyun Kim et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Abrogation of esophageal carcinoma development in miR-31 knockout rats
Louise Y. Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment
Erin Helms et al.
Cancer Discovery (2020)
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
Sarah Bajan et al.
CELLS (2020)
Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
Clodagh P. O'Neill et al.
CELLS (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development
Nina J. Chu et al.
CANCER PREVENTION RESEARCH (2020)
Urinary microRNAs expression in prostate cancer diagnosis: a systematic review
R. M. Paiva et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
Nik Nur Syazana Binti Nik Mohamed Kamal et al.
FRONTIERS IN PHARMACOLOGY (2020)
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo
Meirav Segal et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy
Kentaro Gokita et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Loss of microRNA-21 leads to profound stromal remodeling and short survival in K-Ras-driven mouse models of pancreatic cancer
Josh Schipper et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Post-Transcriptional Dysregulation of microRNA and Alternative Polyadenylation in Colorectal Cancer
Zhanrui Mao et al.
FRONTIERS IN GENETICS (2020)
Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo
Jennifer C. Wischhusen et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia
Francesca Lovat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Spatially resolved and multiplexed MicroRNA quantification from tissue using nanoliter well arrays
Maxwell B. Nagarajan et al.
MICROSYSTEMS & NANOENGINEERING (2020)
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
Diana Bautista-Sanchez et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
Alexis Forterre et al.
CANCERS (2020)
MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods
Rares Drula et al.
CANCERS (2020)
Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases
Humaira Rashid et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
mirnaQC: a webserver for comparative quality control of miRNA-seq data
Ernesto Aparicio-Puerta et al.
NUCLEIC ACIDS RESEARCH (2020)
Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury
Tae Jin Lee et al.
PHARMACOLOGICAL REVIEWS (2020)
Mir34a constrains pancreatic carcinogenesis
Ana Hidalgo-Sastre et al.
SCIENTIFIC REPORTS (2020)
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles
Shipra Malik et al.
JOURNAL OF CONTROLLED RELEASE (2020)
In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor
Hui Hong et al.
PLOS GENETICS (2020)
Identification and transfer of spatial transcriptomics signatures for cancer diagnosis
Niyaz Yoosuf et al.
BREAST CANCER RESEARCH (2020)
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
Ivan Urits et al.
NEUROLOGY AND THERAPY (2020)
Regulation of microRNA function in animals
Luca F. R. Gebert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer
Ying Kong et al.
CANCER BIOMARKERS (2019)
MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis
Xiaoyun Zhang et al.
MEDICINE (2019)
Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH
Chee-Huat Linus Eng et al.
NATURE (2019)
Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics
Rengen Fan et al.
RNA BIOLOGY (2019)
Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution
Samuel G. Rodriques et al.
SCIENCE (2019)
A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes
Naofumi Asano et al.
NATURE COMMUNICATIONS (2019)
Association of High miR-182 Levels with Low-Risk Prostate Cancer
Bethany Baumann et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
The Diagnostic and Prognostic Value of miR-200c in Gastric Cancer: A Meta-Analysis
Zong-Sheng Huang et al.
DISEASE MARKERS (2019)
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy
Siri H. Strand et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Celebrating 25 Years of MicroRNA Research: From Discovery to Clinical Application
Lorenzo F. Sempere
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133
Hongran Yin et al.
MOLECULAR THERAPY (2019)
MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma
Amaia Martinez-Usatorre et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis
Xuan Zou et al.
CANCER MEDICINE (2019)
Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy
Alessandro Bertucci et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer
Dhruvitkumar S. Sutaria et al.
SCIENTIFIC REPORTS (2019)
A novel seven-miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients
Le Lu et al.
MOLECULAR MEDICINE REPORTS (2019)
Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
Maud-Emmanuelle Gilles et al.
Oncotarget (2019)
Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population
Ji Lyu et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
David Bidarra et al.
FRONTIERS IN ONCOLOGY (2019)
Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide
Uday K. Sukumar et al.
BIOMATERIALS (2019)
qPCR-based methods for expression analysis of miRNAs
Diego A. Forero et al.
BIOTECHNIQUES (2019)
Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response
Mahnaz Sahraei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer
Sho Shiino et al.
CLINICAL CANCER RESEARCH (2019)
MiR-15a/16-1 deficiency induces IL-10-producing CD19+ TIM-1+ cells in tumor microenvironment
Xiaoqin Jia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Single-cell microRNA-mRNA co-sequencing reveals non-genetic heterogeneity and mechanisms of microRNA regulation
Nayi Wang et al.
NATURE COMMUNICATIONS (2019)
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages
Jihane Khalife et al.
JCI INSIGHT (2019)
miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
Wenzhu Dai et al.
JOURNAL OF BREAST CANCER (2019)
Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma
Makoto Ohno et al.
JAMA NETWORK OPEN (2019)
MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers
H. Atakan Ekiz et al.
JCI INSIGHT (2019)
Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling
Kazuki Sudo et al.
JAMA NETWORK OPEN (2019)
miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression
Foteini D. Tsikrika et al.
GENES CHROMOSOMES & CANCER (2018)
Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action
Xia Yang et al.
FEBS OPEN BIO (2018)
MicroRNA-493 is a prognostic factor in triple-negative breast cancer
Ling Yao et al.
CANCER SCIENCE (2018)
Personalized RNA Medicine for Pancreatic Cancer
Maud-Emmanuelle Gilles et al.
CLINICAL CANCER RESEARCH (2018)
Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical-related features for axillary lymph node metastasis in early-stage invasive breast cancer
Xinhua Xie et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma
Sayan Mullick Chowdhury et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis
G. Troiano et al.
JOURNAL OF DENTAL RESEARCH (2018)
Clinical utility of circulating non-coding RNAs - an update
Simone Anfossi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
Jiajia Xi et al.
ONCOGENE (2018)
microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer
Sinae Kim et al.
ONCOGENE (2018)
Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer
Rie Kanaoka et al.
ONCOLOGY (2018)
Increased M1 macrophages in young miR-15a/16-/- mice with tumour grafts or dextran sulphate sodium-induced colitis
Xiaoqin Jia et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2018)
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Aaron D. Springer et al.
NUCLEIC ACID THERAPEUTICS (2018)
Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model
Meenakshi Malhotra et al.
Oncotarget (2018)
Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process
Alireza Khodadadi-Jamayran et al.
Oncotarget (2018)
Elevated miR-301a expression indicates a poor prognosis for breast cancer patients
Jin-Zhou Zheng et al.
SCIENTIFIC REPORTS (2018)
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Kaja Skjefstad et al.
SCIENTIFIC REPORTS (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
miRge 2.0 for comprehensive analysis of microRNA sequencing data
Yin Lu et al.
BMC BIOINFORMATICS (2018)
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients
Abeer A. Bahnassy et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
Paloma del C. Monroig-Bosque et al.
SCIENTIFIC REPORTS (2018)
Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma
Rongjiong Zheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Knockout of both miR-15/16 loci induces acute myeloid leukemia
Francesca Lovat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Predictive value of microRNA-10b expression in peripheral blood mononuclear cells in evaluating short- and long-term efficacy of chemotherapy for patients with advanced non-small-cell lung cancer
Y-L Yang et al.
NEOPLASMA (2018)
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Recep Bayraktar et al.
CANCER AND METASTASIS REVIEWS (2018)
Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis
Piotr Kutwin et al.
CENTRAL EUROPEAN JOURNAL OF UROLOGY (2018)
BCL2 and miR-15/16: from gene discovery to treatment
Yuri Pekarsky et al.
CELL DEATH AND DIFFERENTIATION (2018)
Tumor origin detection with tissue-specific miRNA and DNA methylation markers
Wei Tang et al.
BIOINFORMATICS (2018)
Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears
Gila Lithwick-Yanai et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia
N. Narayan et al.
LEUKEMIA (2017)
The pancreatic tumor microenvironment drives changes in miRNA expression that promote cytokine production and inhibit migration by the tumor associated stroma
Song Han et al.
ONCOTARGET (2017)
Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer
Xinyang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade
Thomas B. Huffaker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk et al.
LANCET ONCOLOGY (2017)
Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
Rachid El Fatimy et al.
MOLECULAR THERAPY (2017)
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
Tae Jin Lee et al.
MOLECULAR THERAPY (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles
W. He et al.
ONCOGENE (2017)
A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases
Dan-Dan Xiong et al.
ONCOLOGY REPORTS (2017)
The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
Ricardo Titze-de-Almeida et al.
PHARMACEUTICAL RESEARCH (2017)
miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice (vol 8, e2748, 2017)
Pedro M. Rodrigues et al.
CELL DEATH & DISEASE (2017)
Alternative mechanisms of miR-34a regulation in cancer
Eva Slabakova et al.
CELL DEATH & DISEASE (2017)
MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer
Jing-Hua Li et al.
ONCOTARGET (2017)
MicroRNAs of the mir-17∼92 cluster regulate multiple aspects of pancreatic tumor development and progression
Brian Quattrochi et al.
ONCOTARGET (2017)
miR-29a-deficiency does not modify the course of murine pancreatic acinar carcinoma
James Dooley et al.
ONCOTARGET (2017)
A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma
Xin Zhou et al.
ONCOTARGET (2017)
Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
Xin Guo et al.
ONCOTARGET (2017)
Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance
Chunyu Li et al.
ONCOTARGET (2017)
Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer
Byunghee Yoo et al.
SCIENTIFIC REPORTS (2017)
Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy
Anisha Gupta et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients
Heidi Schwarzenbach
ONCOLOGY RESEARCH AND TREATMENT (2017)
Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications
Lorenzo F. Sempere et al.
CANCERS (2017)
Comparison of miRNA quantitation by Nanostring in serum and plasma samples
Catherine Foye et al.
PLOS ONE (2017)
A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis
Bin Liang et al.
SCIENTIFIC REPORTS (2017)
Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers
Chung Wah Wu et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Conditional knockout of microRNA-31 promotes the development of colitis associated cancer
Zhaoyuan Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response
Jared A. Wallace et al.
BLOOD (2017)
miR-34a and miR-34b/c Suppress Intestinal Tumorigenesis
Longchang Jiang et al.
CANCER RESEARCH (2017)
A microRNA expression signature as a predictor of survival for colon adenocarcinoma
M. Xu et al.
NEOPLASMA (2017)
Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer
Xin Dai et al.
MOLECULAR PHARMACEUTICS (2016)
The utility of urine-circulating miRNAs for detection of prostate cancer
Kristina Stuopelyte et al.
BRITISH JOURNAL OF CANCER (2016)
Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways
Jongchan Kim et al.
CANCER RESEARCH (2016)
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Alexander A. Svoronos et al.
CANCER RESEARCH (2016)
Novel combination of serum microRNA for detecting breast cancer in the early stage
Akihiko Shimomura et al.
CANCER SCIENCE (2016)
Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic
Nadiya M. Teplyuk et al.
EMBO MOLECULAR MEDICINE (2016)
Both cancerous miR-21 and stromal miR-21 in urothelial carcinoma are related to tumour progression
Rena Ohno et al.
HISTOPATHOLOGY (2016)
Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs
Sayan Mullick Chowdhury et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Functional analysis of microRNA-122 binding sequences of hepatitis C virus and identification of variants with high resistance against a specific antagomir
Yi-Ping Li et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Endogenous microRNA sponges: evidence and controversy
Daniel W. Thomson et al.
NATURE REVIEWS GENETICS (2016)
In situ hybridisation: Technologies and their application to understanding disease
Anthony Warford
PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY (2016)
Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-β-mediated MDSC infiltration
Sinae Kim et al.
ONCOTARGET (2016)
Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels
Changfei Li et al.
ONCOTARGET (2016)
The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer
Richard Ottman et al.
ONCOTARGET (2016)
High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer
Nobuyoshi Yamazaki et al.
Oncotarget (2016)
3′UTR Shortening Potentiates MicroRNA-Based Repression of Pro-differentiation Genes in Proliferating Human Cells
Yonit Hoffman et al.
PLOS GENETICS (2016)
Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer
Hong Jiang et al.
CANCER MEDICINE (2016)
miARma-Seq: a comprehensive tool for miRNA, mRNA and circRNA analysis
Eduardo Andres-Leon et al.
SCIENTIFIC REPORTS (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
Dan Shu et al.
ACS NANO (2015)
Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy
Rammohan Devulapally et al.
ACS NANO (2015)
A Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome
Bastian Fromm et al.
ANNUAL REVIEW OF GENETICS, VOL 49 (2015)
Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse
Won Kyung Kang et al.
BMC GASTROENTEROLOGY (2015)
Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer
Sanjay Mishra et al.
CANCER LETTERS (2015)
Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer
Byunghee Yoo et al.
CANCER RESEARCH (2015)
A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis
Doug Hanniford et al.
CLINICAL CANCER RESEARCH (2015)
Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma
Yang Wen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence
Angeline S. Andrew et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology
Emmanuel Labourier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Small molecules targeting microRNA for cancer therapy: Promises and obstacles
Di Wen et al.
JOURNAL OF CONTROLLED RELEASE (2015)
MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma
Pedro M. Costa et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer
Jie Ma et al.
LABORATORY INVESTIGATION (2015)
An allelic series of miR-17∼92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron
Yoon-Chi Han et al.
NATURE GENETICS (2015)
miR-15b/16-2 deletion promotes B-cell malignancies
Francesca Lovat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The oncogenic microRNA miR-21 promotes regulated necrosis in mice
Xiaodong Ma et al.
NATURE COMMUNICATIONS (2015)
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy
Sanchaika Gaur et al.
ONCOTARGET (2015)
Turning 21: induction of miR-21 as a key swith in the inflammatory response
Frederick J. Sheedy
FRONTIERS IN IMMUNOLOGY (2015)
In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
Soren Ottosen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell-Dependent Mechanism
Siqi Chen et al.
CANCER RESEARCH (2015)
MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth
Junfeng Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
A. L. Kasinski et al.
ONCOGENE (2015)
Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues
Sureewan Bumrungthai et al.
PLOS ONE (2015)
miR-34 and p53: New Insights into a Complex Functional Relationship
Francisco Navarro et al.
PLOS ONE (2015)
Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis
Laura Smith et al.
PLOS ONE (2015)
Critical analysis of the potential for microRNA biomarkers in breast cancer management
Carrie R. Graveel et al.
BREAST CANCER-TARGETS AND THERAPY (2015)
Stromal Expression of miR-21 Identifies High-Risk Group in Triple-Negative Breast Cancer
Todd A. MacKenzie et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma
Xiaomin Qian et al.
BIOMATERIALS (2014)
Stage and tissue-specific prognostic impact of miR-182 in NSCLC
Helge Stenvold et al.
BMC CANCER (2014)
microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma
T. O. Yau et al.
BRITISH JOURNAL OF CANCER (2014)
A MicroRNA-Based Test Improves Endoscopic Ultrasound-Guided Cytologic Diagnosis of Pancreatic Cancer
Randall E. Brand et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?
Lorenzo F. Sempere
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
A miR-155-dependent microRNA hierarchy in dendritic cell maturation and macrophage activation
Anne Dueck et al.
FEBS LETTERS (2014)
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
Nobuhiro Okada et al.
GENES & DEVELOPMENT (2014)
MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells
Limin Li et al.
JOURNAL OF IMMUNOLOGY (2014)
Stromal MicroRNA-21 Levels Predict Response to 5-Fluorouracil in Patients With Pancreatic Cancer
Timothy R. Donahue et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer
Christopher L. Daige et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The validity of circulating microRNAs in oncology: Five years of challenges and contradictions
J. Jarry et al.
MOLECULAR ONCOLOGY (2014)
Positive prognostic impact of miR-210 in non-small cell lung cancer
Marte Eilertsen et al.
LUNG CANCER (2014)
miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110
Rui Song et al.
NATURE (2014)
Lessons from miR-143/145: the importance of cell-type localization of miRNAs
Oliver A. Kent et al.
NUCLEIC ACIDS RESEARCH (2014)
Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6
Christian Melbo-Jorgensen et al.
PLOS ONE (2014)
Two miRNA clusters, miR-34b/c and miR-449, are essential for normal brain development, motile ciliogenesis, and spermatogenesis
Jingwen Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome
Helge Stenvold et al.
BMC CLINICAL PATHOLOGY (2014)
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
S. Caponi et al.
ANNALS OF ONCOLOGY (2013)
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
G. Reid et al.
ANNALS OF ONCOLOGY (2013)
A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice
Erika Zonari et al.
BLOOD (2013)
Combined Serum CA19-9 and miR-27a-3p in Peripheral Blood Mononuclear Cells to Diagnose Pancreatic Cancer
Wan-Sheng Wang et al.
CANCER PREVENTION RESEARCH (2013)
Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway
Xiaodong Ma et al.
CARCINOGENESIS (2013)
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
E. Mogilyansky et al.
CELL DEATH AND DIFFERENTIATION (2013)
miR-155 is involved in tumor progression of mycosis fungoides
Lilach Moyal et al.
EXPERIMENTAL DERMATOLOGY (2013)
MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
Jan C. Dudda et al.
IMMUNITY (2013)
mir-17-92: a polycistronic oncomir with pleiotropic functions
Virginie Olive et al.
IMMUNOLOGICAL REVIEWS (2013)
Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma
Junfang Ji et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Oncogenic effects of miR-10b in glioblastoma stem cells
Fadila Guessous et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Prognostic significance of serum miR-17-5p in lung cancer
Qun Chen et al.
MEDICAL ONCOLOGY (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis
M. V. Yigit et al.
ONCOGENE (2013)
Cell-Specific Detection of miR-375 Downregulation for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma by miRNA In Situ Hybridization
Jiangchao Li et al.
PLOS ONE (2013)
Single Cell MicroRNA Analysis Using Microfluidic Flow Cytometry
Meiye Wu et al.
PLOS ONE (2013)
MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury
Chenzhang Shi et al.
PLOS ONE (2013)
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
Brian E. Kadera et al.
PLOS ONE (2013)
Down-Regulation of the miRNA-200 Family at the Invasive Front of Colorectal Cancers with Degraded Basement Membrane Indicates EMT Is Involved in Cancer Progression
Emily L. Paterson et al.
NEOPLASIA (2013)
microRNA Regulation of Inflammatory Responses
Ryan M. O'Connell et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
Jason A. Hanna et al.
BIOTECHNIQUES (2012)
LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas
Yong Zhang et al.
BLOOD (2012)
The prognostic importance of miR-21 in stage II colon cancer: a population-based study
S. Kjaer-Frifeldt et al.
BRITISH JOURNAL OF CANCER (2012)
miR-20a Encoded by the miR-17-92 Cluster Increases the Metastatic Potential of Osteosarcoma Cells by Regulating Fas Expression
Gangxiong Huang et al.
CANCER RESEARCH (2012)
miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adenocarcinoma
Andrea L. Kasinski et al.
CANCER RESEARCH (2012)
Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer
Juan R. Cubillos-Ruiz et al.
CANCER RESEARCH (2012)
Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia
S. Kasar et al.
GENES AND IMMUNITY (2012)
Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis
Xi Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu-hao Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue
John Le Quesne et al.
JOURNAL OF PATHOLOGY (2012)
In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA
Jason A. Hanna et al.
LABORATORY INVESTIGATION (2012)
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
V. J. Craig et al.
LEUKEMIA (2012)
A Second-Generation MicroRNA-Based Assay for Diagnosing Tumor Tissue Origin
Eti Meiri et al.
ONCOLOGIST (2012)
miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma
Cheng-Kui Cai et al.
ONCOLOGY REPORTS (2012)
Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
Amanda Tivnan et al.
PLOS ONE (2012)
Comparing the MicroRNA Spectrum between Serum and Plasma
Kai Wang et al.
PLOS ONE (2012)
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Imran A. Babar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Unmet Expectations: miR-34 Plays No Role in p53-Mediated Tumor Suppression In Vivo
Abhinav K. Jain et al.
PLOS GENETICS (2012)
Intact p53-Dependent Responses in miR-34-Deficient Mice
Carla P. Concepcion et al.
PLOS GENETICS (2012)
miR-34 – a microRNA replacement therapy is headed to the clinic
Andreas G. Bader
Frontiers in Genetics (2012)
Human Glioma Growth Is Controlled by MicroRNA-10b
Galina Gabriely et al.
CANCER RESEARCH (2011)
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Leonardo Salmena et al.
CELL (2011)
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
Boye Schnack Nielsen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
Meir Preis et al.
CLINICAL CANCER RESEARCH (2011)
Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma
Anna E. Szafranska-Schwarzbacht et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
miR-17∼92 cooperates with RB pathway mutations to promote retinoblastoma
Karina Conkrite et al.
GENES & DEVELOPMENT (2011)
Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization
Tom Donnem et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
Phong Trang et al.
MOLECULAR THERAPY (2011)
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Yong Jin Choi et al.
NATURE CELL BIOLOGY (2011)
Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis
Xiaodong Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Mark E. Hatley et al.
CANCER CELL (2010)
The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
Ulf Klein et al.
CANCER CELL (2010)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors
Lorenzo F. Sempere et al.
CLINICAL CANCER RESEARCH (2010)
MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
Mael Chalret du Rieu et al.
CLINICAL CHEMISTRY (2010)
Analysis of microRNA knockouts in mice
Chong Y. Park et al.
HUMAN MOLECULAR GENETICS (2010)
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Yunching Chen et al.
MOLECULAR THERAPY (2010)
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Pedro P. Medina et al.
NATURE (2010)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Li Ma et al.
NATURE BIOTECHNOLOGY (2010)
Regression of murine lung tumors by the let-7 microRNA
P. Trang et al.
ONCOGENE (2010)
Comprehensive microRNA expression profiling of the hematopoietic hierarchy
O. I. Petriv et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
Christine Mayr et al.
CELL (2009)
miR-19 is a key oncogenic component of mir-17-92
Virginie Olive et al.
GENES & DEVELOPMENT (2009)
Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity
Erica Salerno et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma
Tamar Uziel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
Aurora Esquela-Kerscher et al.
CELL CYCLE (2008)
hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer
Carme Camps et al.
CLINICAL CANCER RESEARCH (2008)
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Desiree Bonci et al.
NATURE MEDICINE (2008)
Suppression of non-small cell lung tumor development by the let-7 microRNA family
Madhu S. Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MiR-15a and miR-16-1 cluster functions in human leukemia
George A. Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNAs and cancer: Profile, profile, profile
Elisa Barbarotto et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Altered microRNA expression confined to specific epithelial cell Subpopulations in breast cancer
Lorenzo F. Sempere et al.
CANCER RESEARCH (2007)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
Regulation of the germinal center response by microRNA-155
To-Ha Thai et al.
SCIENCE (2007)
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
S Costinean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues
CG Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Microarray-based, high-throughput gene expression profiling of microRNAs
PT Nelson et al.
NATURE METHODS (2004)
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation
LF Sempere et al.
GENOME BIOLOGY (2004)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
